InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
0
T+90 hit rate
8%
T+90 mean return
-9.8%
Across 12 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Certimab Control, S.l.. Insider active across 1 company, notably Alantra Partners, S.A.. Aggregated, 41 disclosures have been published. Activity tracked since 9 June 2023. The latest transaction was disclosed on 27 May 2026 (Purchase). Regulator: CNMV. All data is openly available.
Companies and markets linked to Certimab Control, S.l.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations41 total
3,000 shares@ €10.200.0079% mcap2.6% of flowShareXMADISIN ES0126501131CNMV:2026074983
5,000 shares@ €10.200.013% mcap4.4% of flowShareXMADISIN ES0126501131CNMV:2026074285
10,000 shares@ €10.200.026% mcap8.7% of flowShareXMADISIN ES0126501131CNMV:2026073070
1,144 shares@ €10.050.0030% mcap1.0% of flowShareXMADISIN ES0126501131CNMV:2026072430
5,534 shares@ €10.200.015% mcap4.8% of flowShareXMADISIN ES0126501131CNMV:2026072547
1,913 shares@ €10.200.0051% mcap1.7% of flowShareXMADISIN ES0126501131CNMV:2026071686
5,000 shares@ €10.100.013% mcap4.3% of flowShareXMADISIN ES0126501131CNMV:2026071517
5,000 shares@ €10.150.013% mcap4.3% of flowShareXMADISIN ES0126501131CNMV:2026070483
20,000 shares@ €10.050.052% mcap17.2% of flowShareXMADISIN ES0126501131CNMV:2026067270
50,000 shares@ €8.000.10% mcap50.1% of flowShareXMADISIN ES0126501131CNMV:2025119951
1,413 shares@ €9.500.0035% mcap1.7% of flowShareXMADISIN ES0126501131CNMV:2023111129
61 shares@ €9.600.0002% mcap0.1% of flowShareXMADISIN ES0126501131CNMV:2023109648
1,557 shares@ €9.600.0039% mcap1.9% of flowShareXMADISIN ES0126501131CNMV:2023108655
25 of 41 declarations
About Certimab Control, S.l.
CERTIMAB CONTROL, S.L. is a declarant with 21 filings in total. Across the 21 recent filings sampled, all are purchases in Alantra Partners, S.A., for a total of EUR 799186, between 2023-06-13 and 2026-05-11.
